Boehringer appeals win for Merck in parasite patent spat

Appeals 2020-10-13 12:00 pm By Cat Fredenburgh

Please login to bookmark

Pharmaceutical company Boehringer Ingelheim will take another crack at opposing a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au